Vitamin B12 Deficiency Masquerading as TTP: Daniela Hermelin’s Life-Saving Diagnostic Reminder
Daniela Hermelin, Chief Medical Officer of ImpactLife Blood Center, posted on LinkedIn:
”Pseudo TTP. I see this phenomenon about once a year, and you don’t want to miss it.
23-year-old female presents with a month of lethargy and a change in mental status. ED Labs show a striking anemia, Hb = 4.5 g/dL and low platelets of 60K. She also has evidence of a microangiopathic hemolytic anemia (MAHA).
Boy, that’s a mouthful. To break that down, she has evidence of hemolysis (red cell destruction – absent haptoglobin, elevated LDH, and increased indirect bilirubin). And this red cell destruction occurs through a shearing process, the red cells are being shredded.
How? MAHAs can occur when small microthrombi form in the microvasculature and red cells are sheared as they pass through the circulation. Under the microscope, we would find sheared red blood cells called schistocytes.
Now that sounds a lot like thrombotic thrombocytopenia purpura, otherwise known as TTP. But in this case, it’s not due to deficiency in ADAMTS13, but it is caused by SEVERE Vitamin B12 deficiency. And in every case, I have ever seen, it is in the setting of pernicious anemia. Anti-intrinsic factor antibodies will be positive.
How can you tell the difference between Pseudo and REAL TTP, and avoid performing therapeutic plasma exchange when it is not necessary?
Big clues and little clues.
Big clue – measure Vitamin B12.
Little clue – review the peripheral smear. It will show evidence of a megaloblastic anemia, HYPERSEGMENTED neutrophils, and bone marrow dysfunction with tear-drop cells (dacrocytes). These are not findings in TTP.
Check out this article: When the diagnosis is difficult to digest: severe vitamin B12 deficiency secondary to pernicious anemia mimicking life-threatening thrombotic thrombocytopenic purpura
to learn more about this disease and keep it on your differential.”
Title: When the diagnosis is difficult to digest: severe vitamin B12 deficiency secondary to pernicious anemia mimicking life-threatening thrombotic thrombocytopenic purpura
Authors: Matthew Sochat, Daniela Hermelin, Daniel Chakos, Azam Farooqui, Jason Lunt, Ara Vartanyan, Nishant Poddar

Stay informed with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia